Viridian Therapeutics, Inc.\DE (VRDN) Treasury Shares (2014 - 2026)

Viridian Therapeutics, Inc.\DE's Treasury Shares history runs 8 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 45.2% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a 45.2% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 238.89% from the prior year.
• Treasury Shares climbed to $1.6 million in Q1 2026 per VRDN's latest filing, from $1.1 million in the prior quarter.
• Across five years, Treasury Shares topped out at $1.6 million in Q1 2026 and bottomed at $250000.0 in Q1 2023.
• The 4-year median for Treasury Shares is $804947.0 (2023), against an average of $838860.6.
• Across the five-year window, Treasury Shares plunged 60.98% in 2024 and surged 238.89% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $804947.0 in 2023, then plunged by 60.98% to $314075.0 in 2024, then jumped by 238.89% to $1.1 million in 2025, then surged by 53.95% to $1.6 million in 2026.
• Per Business Quant, the three latest VRDN Treasury Shares figures stand at $1.6 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025).